1. Home
  2. GGRP vs LEXX Comparison

GGRP vs LEXX Comparison

Compare GGRP & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Glimpse Group Inc. Common Stock

GGRP

The Glimpse Group Inc. Common Stock

N/A

Current Price

$0.77

Market Cap

16.5M

Sector

Technology

ML Signal

N/A

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.61

Market Cap

16.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GGRP
LEXX
Founded
2016
2004
Country
United States
Canada
Employees
40
7
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.5M
16.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GGRP
LEXX
Price
$0.77
$0.61
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
129.9K
58.3K
Earning Date
05-15-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$72.00
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.42
$0.46
52 Week High
$0.94
$1.55

Technical Indicators

Market Signals
Indicator
GGRP
LEXX
Relative Strength Index (RSI) 51.26 52.60
Support Level $0.73 $0.57
Resistance Level $0.94 $0.70
Average True Range (ATR) 0.09 0.05
MACD -0.01 0.01
Stochastic Oscillator 28.99 73.83

Price Performance

Historical Comparison
GGRP
LEXX

About GGRP The Glimpse Group Inc. Common Stock

The Glimpse Group Inc is a diversified immersive technology platform company, focused on providing enterprise solutions in virtual reality (VR), augmented reality (AR), and spatial computing. The company operates multiple subsidiaries that develop VR and AR software and services across various industries, including corporate training, education, healthcare, government, defense, marketing, retail, and financial services. It also offers AI-driven spatial computing platforms that support simulations, social VR, behavioral health, and corporate events. The Company reports its revenues in three categories: Software Services, Software License and Software-as-a-Service (SaaS), and Royalty Income, with the majority being from the Software Services category.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: